Company intelligence / Profile preview

Frelii

Salt Lake City, Utah, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Frelii offers a commercial, web-based subscription service that ingests users’ raw genetic data (e.g., from 23andMe) and uses its Navii AI platform and DNA analysis to generate personalized nutrition, fitness, supplement, and wellness plans, as well as health-risk assessments for consumers and health providers.[1][2][3][5]

Therapeutic areas: OtherMetabolic Disorders
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Frelii.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frelii.

Explore the full profile